ABVC Biopharma Files Definitive Proxy Statement
Ticker: ABVC · Form: DEF 14A · Filed: May 16, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | DEF 14A |
| Filed Date | May 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
ABVC Bio proxy out for June 3rd meeting - vote on directors & pay.
AI Summary
ABVC Biopharma, Inc. filed its Definitive Proxy Statement (DEF 14A) on May 16, 2025, for its annual meeting on June 3, 2025. The filing details the company's governance and proposals to be voted on by shareholders, including the election of directors and approval of executive compensation plans. The company, formerly known as American BriVision (Holding) Corp, is based in Fremont, CA.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and executive compensation, impacting the company's strategic direction and financial health.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specific proposals and shareholder votes can significantly impact a company's future operations and stock performance.
Key Numbers
- 001-40700 — SEC File Number (Identifies the company's filings with the SEC.)
- 25959746 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- American BriVision (Holding) Corp (company) — Former company name
- 20250516 (date) — Filing date
- 20250603 (date) — Meeting date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the upcoming annual meeting on June 3, 2025, including proposals for voting on director elections and executive compensation.
When was this Definitive Proxy Statement filed with the SEC?
This Definitive Proxy Statement was filed on May 16, 2025.
What is the company's current address as listed in the filing?
The company's business and mailing address is 44370 OLD WARM SPRINGS BLVD., FREMONT, CA 94538.
Has ABVC Biopharma, Inc. operated under any previous names?
Yes, the company was formerly known as American BriVision (Holding) Corp, METU BRANDS, INC., and ECOLOGY COATINGS, INC.
What is the fiscal year end for ABVC Biopharma, Inc.?
The company's fiscal year ends on December 31.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 16, 2025 regarding ABVC BIOPHARMA, INC. (ABVC).